114
Views
6
CrossRef citations to date
0
Altmetric
Article

High Serum Uric Acid Levels Could Be a Risk Factor of Hepatocellular Carcinoma Recurrences

ORCID Icon, ORCID Icon, , , , , ORCID Icon, , ORCID Icon, , , , & ORCID Icon show all
Pages 996-1003 | Received 06 Jan 2020, Accepted 29 May 2020, Published online: 15 Jun 2020

References

  • Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
  • Leung C, Yeoh SW, Patrick D, et al. Characteristics of hepatocellular carcinoma in cirrhotic and non-cirrhotic non-alcoholic fatty liver disease. World J Gastroenterol. 2015;21(4):1189–1196. doi:10.3748/wjg.v21.i4.1189
  • Yiu A, Van Hemelrijck M, Garmo H, Holmberg L, Malmström H, Lambe M, Hammar N, Walldius G, Jungner I, Wulaningsih W, et al. Circulating uric acid levels and subsequent development of cancer in 493,281 individuals: findings from the AMORIS Study. Oncotarget. 2017;8(26):42332–42342. doi:10.18632/oncotarget.16198
  • Du X-J, Chen L, Li W-F, Tang L-L, Mao Y-P, Guo R, Sun Y, Lin A-H, Ma J. Use of pretreatment serum uric acid level to predict metastasis in locally advanced nasopharyngeal carcinoma. Head Neck. 2017;39(3):492–497. doi:10.1002/hed.24631
  • Chen Y-F, Li Q, Chen D-T, Pan J-H, Chen Y-H, Wen Z-S, Zeng W-A. Prognostic value of pre-operative serum uric acid levels in esophageal squamous cell carcinoma patients who undergo R0 esophagectomy. Cancer Biomark. 2016;17(1):89–96. doi:10.3233/CBM-160621
  • Fini MA, Elias A, Johnson RJ, Wright RM. Contribution of uric acid to cancer risk, recurrence, and mortality. Clin Transl Med. 2012;1(1):16. doi:10.1186/2001-1326-1-16
  • Chen G-L, Ye T, Chen H-L, Zhao Z-Y, Tang W-Q, Wang L-S, Xia J-L. Xanthine dehydrogenase downregulation promotes TGFβ signaling and cancer stem cell-related gene expression in hepatocellular carcinoma . Oncogenesis. 2017;6(9):e382. doi:10.1038/oncsis.2017.81
  • Ebrahimi R, Shanaki M, Mohassel Azadi S, Bahiraee A, Radmard AR, Poustchi H, Emamgholipour S. Low level of adiponectin predicts the development of nonalcoholic fatty liver disease: is it irrespective to visceral adiposity index, visceral adipose tissue thickness and other obesity indices? Arch Physiol Biochem. 2019;Sep 4:1–8. doi:10.1080/13813455.2019.1661496
  • Wong CR, Nguyen MH, Lim JK. Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease. World J Gastroenterol. 2016;22(37):8294–8303. doi:10.3748/wjg.v22.i37.8294
  • Shin E, Yu YD, Kim DS, Won NH. Adiponectin receptor expression predicts favorable prognosis in cases of hepatocellular carcinoma. Pathol Oncol Res. 2014;20(3):667–675. doi:10.1007/s12253-014-9747-0
  • Ruff SM, Rothermel LD, Diggs LP, Wach MM, Ayabe RI, Martin SP, Boulware D, Anaya D, Davis JL, Mullinax JE, et al. Tumor grade may be used to select patients with multifocal hepatocellular carcinoma for resection. HPB (Oxford). 2019;S1365-182X(19):32273–32277. doi:10.1016/j.hpb.2019.10.1531
  • Silva MTD, Diniz M, Coelho CG, Vidigal PG, Telles RW, Barreto SM. Intake of selected foods and beverages and serum uric acid levels in adults: ELSA-Brasil (2008–2010). Public Health Nutr. 2020;23(3):506–509. doi:10.1017/S1368980019002490
  • Mosca A, Nobili V, De Vito R, Crudele A, Scorletti E, Villani A, Alisi A, Byrne CD. Serum uric acid concentrations and fructose consumption are independently associated with NASH in children and adolescents. J Hepatol. 2017;66(5):1031–1036. doi:10.1016/j.jhep.2016.12.025
  • Li S, Sanna S, Maschio A, Busonero F, Usala G, Mulas A, Lai S, Dei M, Orrù M, Albai G, et al. The GLUT9 gene is associated with serum uric acid levels in Sardinia and Chianti cohorts. PLoS Genet. 2007;3(11):e194. doi:10.1371/journal.pgen.0030194
  • Fernandez Rodriguez CM, Aller R, Gutierrez Garcia ML, et al. Higher levels of serum uric acid influences hepatic damage in patients with non-alcoholic fatty liver disease (NAFLD). Rev Esp Enferm Dig. 2019;111(4):264–269.
  • Hernandez-Alejandro R, Croome KP, Drage M, et al. A comparison of survival and pathologic features of non-alcoholic steatohepatitis and hepatitis C virus patients with hepatocellular carcinoma. World J Gastroenterol. 2012;18(31):4145–4149. doi:10.3748/wjg.v18.i31.4145
  • Li Y, Cao T-T, Guo S, Zhong Q, Li C-H, Li Y, Dong L, Zheng S, Wang G, Yin S-F, et al. Discovery of novel allopurinol derivatives with anticancer activity and attenuated xanthine oxidase inhibition. Molecules (Basel, Switzerland). 2016;21(6):771. doi:10.3390/molecules21060771
  • Shih HJ, Kao MC, Tsai PS, Fan YC, Huang CJ. Long-term allopurinol use decreases the risk of prostate cancer in patients with gout: a population-based study. Prostate Cancer Prostatic Dis. 2017;20(3):328–333. doi:10.1038/pcan.2017.14
  • Kuo M-C, Chang S-J, Hsieh M-C. Colchicine significantly reduces incident cancer in gout male patients: a 12-year cohort study. Medicine (Baltimore)). 2015;94(50):e1570. doi:10.1097/MD.0000000000001570

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.